Ignite Creation Date:
2024-05-06 @ 6:19 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05629741
Status:
TERMINATED
Last Update Posted:
2024-03-08
First Post:
2022-11-09
Brief Title:
A 2-Part First-in-Human Study to Evaluate the Safety Tolerability Pharmacokinetics and Immunogenicity of CMTX-101
Sponsor:
Organization:
Clarametyx Biosciences Inc